Tag archive for ‘Pluristem’

FDA awards Israeli stem cell co Pluristem orphan drug status

  Israeli placenta-based cell therapy developer Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has been awarded orphan drug status by the US Food and Drug Administration (FDA) for its PLX-PAD More...

Pluristem Signs Korean Licensing Deal : Includes $10 million Share Swap

– – The Israeli stem cell company, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has signed a strategic partnership and exclusive licensing agreement with South Korea’s Cha Bio&Diostech More...

Wordpress site Developed by Fixing WordPress Problems